Radnostix, Inc. (INIS)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Theranostics Products			6.84M	6.05M	4.28M	4.07M	2.85M
Theranostics Products Growth			13.18%	41.42%	5.00%	42.75%	25.98%
Cobalt Products			1.04M	1.16M	1.35M	1.23M	846.40K
Cobalt Products Growth			-10.41%	-14.54%	10.52%	44.80%	-58.54%
Calibration & Reference Products			4.39M	3.98M	-	-	-
Calibration & Reference Products Growth			10.27%	-	-	-	-
Fluorine Products			-	-	29.78K	178.35K	160.50K
Fluorine Products Growth			-	-	-83.31%	11.12%	-
Nuclear Medicine Standards			-	-	4.00M	3.67M	3.93M
Nuclear Medicine Standards Growth			-	-	8.97%	-6.42%	3.60%
Radiological Services (Incl. Transportation)			-	-	-	216.14K	1.17M
Radiological Services (Incl. Transportation) Growth			-	-	-	-81.54%	-48.52%
Total			12.27M	11.18M	9.66M	9.36M	8.96M
Total Growth			9.71%	15.73%	3.17%	4.57%	-13.63%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States			-	9.65M	8.20M	8.08M	7.26M
United States Growth			-	17.68%	1.41%	11.32%	-12.06%
outside United States			-	1.53M	1.46M	1.28M	1.69M
outside United States Growth			-	4.79%	14.29%	-24.36%	-19.81%
Total			-	11.18M	9.66M	9.36M	8.96M
Total Growth			-	15.73%	3.17%	4.57%	-13.63%

Source: S&P Global Market Intelligence.